These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33240367)

  • 21. The Stimulant Selective Severity Assessment: A replication and exploratory extension of the Cocaine Selective Severity Assessment.
    Walker R; Northrup TF; Tillitski J; Bernstein I; Greer TL; Trivedi MH
    Subst Use Misuse; 2019; 54(3):351-361. PubMed ID: 30657406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.
    Sajja RK; Rahman S; Cucullo L
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):539-54. PubMed ID: 26661236
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986-2002.
    Forrester MB; Merz RD
    J Toxicol Environ Health A; 2007 Jan; 70(1):7-18. PubMed ID: 17162495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug-related decrease in neuropsychological functions of abstinent drug users.
    van Holst RJ; Schilt T
    Curr Drug Abuse Rev; 2011 Mar; 4(1):42-56. PubMed ID: 21466500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine use and dental disease: results of a pilot study.
    Cretzmeyer M; Walker J; Hall JA; Arndt S
    J Dent Child (Chic); 2007; 74(2):85-92. PubMed ID: 18477425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 gp120 and drugs of abuse: interactions in the central nervous system.
    Silverstein PS; Shah A; Weemhoff J; Kumar S; Singh DP; Kumar A
    Curr HIV Res; 2012 Jul; 10(5):369-83. PubMed ID: 22591361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preface. Emerging targets and therapeutics in the treatment of psychostimulant abuse.
    Dwoskin LP
    Adv Pharmacol; 2014; 69():xi-xiii. PubMed ID: 24484989
    [No Abstract]   [Full Text] [Related]  

  • 28. [Speed users (metamphetamines): a return journey between ecstasy (MDMA) and cocaine. Clinical, preventive and health-care questions].
    Royo-Isach J; Magrané M; Velilla A; Ruiz L
    Aten Primaria; 2004 Dec; 34(10):553-6. PubMed ID: 15607059
    [No Abstract]   [Full Text] [Related]  

  • 29. Polysubstance Use by Stimulant Users: Health Outcomes Over Three Years.
    Timko C; Han X; Woodhead E; Shelley A; Cucciare MA
    J Stud Alcohol Drugs; 2018 Sep; 79(5):799-807. PubMed ID: 30422794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulant Drugs of Abuse and Cardiac Arrhythmias.
    Dominic P; Ahmad J; Awwab H; Bhuiyan MS; Kevil CG; Goeders NE; Murnane KS; Patterson JC; Sandau KE; Gopinathannair R; Olshansky B
    Circ Arrhythm Electrophysiol; 2022 Jan; 15(1):e010273. PubMed ID: 34961335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ageing and older people who use illicit opioids, cocaine or methamphetamine: a scoping review and literature map.
    Zolopa C; Høj SB; Minoyan N; Bruneau J; Makarenko I; Larney S
    Addiction; 2022 Aug; 117(8):2168-2188. PubMed ID: 35072313
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Do prenatally methamphetamine-exposed adult male rats display general predisposition to drug abuse in the conditioned place preference test?
    Šlamberová R; Pometlová M; Schutová B; Hrubá L; Macúchová E; Nová E; Rokyta R
    Physiol Res; 2012; 61(Suppl 2):S129-38. PubMed ID: 23130898
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methamphetamine: an update on epidemiology, pharmacology, clinical phenomenology, and treatment literature.
    Courtney KE; Ray LA
    Drug Alcohol Depend; 2014 Oct; 143():11-21. PubMed ID: 25176528
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The recent expansion in the Australian cocaine market: who are the new users and what are the harms?
    Chalmers J; Matthew-Simmons F; Hughes CE
    Curr Drug Abuse Rev; 2013 Jun; 6(2):98-111. PubMed ID: 24308523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacological Treatment of Methamphetamine/Amphetamine Dependence: A Systematic Review.
    Siefried KJ; Acheson LS; Lintzeris N; Ezard N
    CNS Drugs; 2020 Apr; 34(4):337-365. PubMed ID: 32185696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effects and management of methamphetamine abuse.
    Romanelli F; Smith KM
    Pharmacotherapy; 2006 Aug; 26(8):1148-56. PubMed ID: 16863490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gray matter abnormalities in cocaine versus methamphetamine-dependent patients: a neuroimaging meta-analysis.
    Hall MG; Alhassoon OM; Stern MJ; Wollman SC; Kimmel CL; Perez-Figueroa A; Radua J
    Am J Drug Alcohol Abuse; 2015; 41(4):290-9. PubMed ID: 26125488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trace amine-associated receptor 1: A promising target for the treatment of psychostimulant addiction.
    Jing L; Li JX
    Eur J Pharmacol; 2015 Aug; 761():345-52. PubMed ID: 26092759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methamphetamine abuse: a review of the literature and case report in a young male.
    Naidoo S; Smit D
    SADJ; 2011 Apr; 66(3):124-7. PubMed ID: 21874893
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sonographic findings in methamphetamine-induced ischemic colitis.
    Dirkx CA; Gerscovich EO
    J Clin Ultrasound; 1998; 26(9):479-82. PubMed ID: 9800164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.